Is helicobacter pylori infection a risk factor for coronary heart disease?
Mehran Rogha1, Marjan Nikvarz, Zahra Pourmoghaddas
1Assistant Professor, Department of Internal Medicine, School of Medicine, Najafabad Branch, Islamic Azad University, Isfahan, Iran.
Insights
Helicobacter pylori (H. pylori) infection is linked to coronary heart disease (CHD) in Iranians. This risk factor is independent of common conditions like diabetes and hypertension.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- The association between Helicobacter pylori (H. pylori) infection and coronary heart disease (CHD) remains controversial.
- This study investigates the potential link between H. pylori infection and CHD in an Iranian population.
Purpose of the Study:
- To evaluate the association between H. pylori infection and the presence of coronary heart disease (CHD).
- To determine if H. pylori infection is an independent risk factor for CHD.
Main Methods:
- 112 patients undergoing coronary angiography provided blood samples for H. pylori IgG, C-reactive protein (CRP), and interleukin-6 (IL-6) measurements.
- Patients were categorized into CHD (n=62) and non-CHD (n=43) groups based on angiography results.
- Multivariate logistic regression adjusted for age, sex, diabetes mellitus (DM), dyslipidemia (DLP), hypertension (HTN), CRP, and IL-6 levels.
Main Results:
- Multivariate analysis revealed a significant association between H. pylori infection and CHD (OR 3.18, 95% CI 1.08-9.40).
- This association remained significant after adjusting for traditional CHD risk factors and inflammatory markers.
Conclusions:
- H. pylori infection is identified as a probable risk factor for coronary heart disease.
- The link between H. pylori and CHD is independent of common comorbidities such as DM, DLP, HTN, and inflammatory markers (CRP, IL-6).
Background:
There is still controversy about association of Helicobacter pylori (H. pylori) infection with coronary heart disease (CHD). This study designed to evaluate this association in a sample of Iranians Population.
Methods:
Medical and drug history as well as fasting blood samples of 112 consecutive patients who were candidate for coronary angiography were taken on catheterization day. Fasting blood samples were used to measure C-reactive protein (CRP), anti H. pylori immunoglobulin G (anti H. pylori IgG) and interlukine-6 (IL6). According to angiography reports, participants were divided into patients with (n = 62) or without CHD (n = 43). To compare the association between H. pylori infection with CHD, multivariate logistic regression tests were used by adjusting sex and age, age and sex plus history of diabetes mellitus (DM), Dyslipidemia (DLP), and/or hypertension (HTN), CRP status and IL-6 level.
Results:
Sixty two patients with CHD and 43 participants without CHD were enrolled in the present study. The mean ages of patients with and without CHD were 62.4 261 9.5 and 59.0 261 10.5 years respectively. Multivariate logistic regression analysis after adjusting for history of DM and/or DLP and/or HTN plus CRP status and IL-6 level showed significant association of H. pylori infection with CHD (OR 3.18, 95%CI 1.08-9.40).
Conclusion:
H. pylori infection is one of the probable risk factors for CHD independent of history of DM, DLP, HTN, CRP status and IL-6 level.
Related Concept Videos
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

